Evidence in support of potential applications of lipid peroxidation products in cancer treatment

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Erejuwa, Omotayo O ^a   Sulaiman, Siti A ^a   Ab Wahab, Mohd S ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; HUMAN; LIPID PEROXIDATION; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

CELL PROLIFERATION; HUMANS; LIPID PEROXIDATION; NEOPLASMS;

EID: 84893872939     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/931251     Document Type: Article

References (85)

1. Shulaev V., Oliver D. J., Metabolic and proteomic markers for oxidative stress: new tools for reactive oxygen species research. Plant Physiology 2006 141 2 367 372 2-s2.0-33745674718 10.1104/pp.106.077925 (Pubitemid 43974529)
2. Yoshida Y., Umeno A., Shichiri M., Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo. Journal of Clinical Biochemistry and Nutrition 2013 52 1 9 16
3. Matveychuk D., Dursun S. M., Wood P. L., Baker G. B., Reactive aldehydes and neurodegenerative disorders. Bulletin of Clinical Psychopharmacology 2011 21 4 277 288 2-s2.0-82255185988 10.5455/bcp.19691231040000
4. Catalá A., A synopsis of the process of lipid peroxidation since the discovery of the essential fatty acids. Biochemical and Biophysical Research Communications 2010 399 3 318 323 2-s2.0-77956180789 10.1016/j.bbrc.2010.07.087
5. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6 (Pubitemid 121003917)
6. Butterfield D. A., Bader Lange M. L., Sultana R., Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochimica et Biophysica Acta 2010 1801 8 924 929 2-s2.0-77953257870 10.1016/j.bbalip.2010.02.005
7. Fukuda M., Kanou F., Shimada N., Sawabe M., Saito Y., Murayama S., Hashimoto M., Maruyama N., Ishigami A., Elevated levels of 4-hydroxynonenal- histidine Michael adduct in the hippocampi of patients with Alzheimer's disease. Biomedical Research 2009 30 4 227 233 2-s2.0-70349386042 10.2220/biomedres.30. 227
8. Höhn A., Grune T., Lipofuscin: formation, effects and role of macroautophagy. Redox Biology 2013 1 1 140 144
9. Erejuwa O. O., Sulaiman S. A., Ab Wahab M. S., Sirajudeen K. N. S., Salleh S., Gurtu S., Honey supplementation in spontaneously hypertensive rats elicits antihypertensive effect via amelioration of renal oxidative stress. Oxidative Medicine and Cellular Longevity 2012 2012 14 2-s2.0-84858328733 10.1155/2012/374037 374037
10. Butterfield D. A., Galvan V., Lange M. B., Tang H., Sowell R. A., Spilman P., Fombonne J., Gorostiza O., Zhang J., Sultana R., Bredesen D. E., In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid β -peptide of APP. Free Radical Biology and Medicine 2010 48 1 136 144 2-s2.0-74149091007 10.1016/j.freeradbiomed.2009.10. 035
11. Zanini D., Schmatz R., Pelinson L. P., Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer. Molecular and Cellular Biochemistry 2013 374 1-2 137 148
12. Erejuwa O. O., Sulaiman S. A., Wahab M. S., Salam S. K. N., Salleh M. S., Gurtu S., Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. International Journal of Molecular Sciences 2011 12 1 829 843 2-s2.0-79251635076 10.3390/ijms12010829
13. Tsikas D., Suchy M. T., Niemann J., Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2alpha. FEBS Letters 2012 586 20 3723 3730
14. Guichardant M., Chen P., Liu M., Calzada C., Colas R., Véricel E., Lagarde M., Functional lipidomics of oxidized products from polyunsaturated fatty acids. Chemistry and Physics of Lipids 2011 164 6 544 548 2-s2.0-80051470268 10.1016/j.chemphyslip.2011.05.002
15. Gasparovic A. C., Jaganjac M., Mihaljevic B., Sunjic S. B., Zarkovic N., Assays for the measurement of lipid peroxidation. Methods Molecular Biology 2013 965 283 296
16. Feng Z., Hu W., Marnett L. J., Tang M.-S., Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV- and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair. Mutation Research 2006 601 1-2 125 136 2-s2.0-33749527349 10.1016/j.mrfmmm.2006.06.003 (Pubitemid 44528597)
17. Niedernhofer L. J., Daniels J. S., Rouzer C. A., Greene R. E., Marnett L. J., Malondialdehyde: a product of lipid peroxidation, is mutagenic in human cells. Journal of Biological Chemistry 2003 278 33 31426 31433 2-s2.0-0041731614 10.1074/jbc.M212549200 (Pubitemid 36994664)
18. Grotto D., Santa Maria L., Valentini J., Paniz C., Schmitt G., Garcia S. C., Pomblum V. J., Rocha J. B. T., Farina M., Importance of the lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quimica Nova 2009 32 1 169 174 2-s2.0-62749141950 10.1590/S0100-40422009000100032
19. Catalá A., Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chemistry and Physics of Lipids 2009 157 1 1 11 2-s2.0-57249095767 10.1016/j.chemphyslip.2008.09.004
20. Reed T. T., Pierce W. M., Markesbery W. R., Butterfield D. A., Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Research 2009 1274 66 76 2-s2.0-67349279818 10.1016/j.brainres.2009.04.009
21. Perluigi M., Coccia R., Butterfield D. A., 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxidants and Redox Signaling 2012 17 11 1590 1609
22. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., Mattson M. P., Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β -peptide: role of the lipid peroxidation product 4-hydroxynonenal. Journal of Neurochemistry 1997 69 1 273 284 2-s2.0-0030966546 (Pubitemid 27274182)
23. Neely M. D., Boutte A., Milatovic D., Montine T. J., Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Research 2005 1037 1-2 90 98 2-s2.0-14944338510 10.1016/j.brainres.2004.12.027 (Pubitemid 40362384)
24. Anderson M. M., Hazen S. L., Hsu F. F., Heinecke J. W., Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein: a mechanism for the generation of highly reactive α -hydroxy and α β -unsaturated aldehydes by phagocytes at sites of inflammation. Journal of Clinical Investigation 1997 99 3 424 432 2-s2.0-0030854261 (Pubitemid 27414799)
25. Nakamura M., Tomitori H., Suzuki T., Inactivation of GAPDH as one mechanism of acrolein toxicity. Biochemical and Biophysical Research Communications 2013 430 4 1265 1271
26. Huang Y. J., Jin M. H., Pi R. B., Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo. Toxicology Letters 2013 217 3 184 191
27. Morrow J. D., Hill K. E., Burk R. F., Nammour T. M., Badr K. F., Roberts L. J. II, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proceedings of the National Academy of Sciences of the United States of America 1990 87 23 9383 9387 2-s2.0-0025572704 10.1073/pnas.87.23.9383 (Pubitemid 120030630)
28. Il'yasova D., Scarbrough P., Spasojevic I., Urinary biomarkers of oxidative status. Clinica Chimica Acta 2012 413 19-20 1446 1453
29. Basu S., F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxidants and Redox Signaling 2008 10 8 1405 1434 2-s2.0-51749090447 10.1089/ars.2007.1956
30. Montine T. J., Montine K. S., McMahan W., Markesbery W. R., Quinn J. F., Morrow J. D., F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxidants and Redox Signaling 2005 7 1-2 269 275 2-s2.0-13244271257 10.1089/ars.2005.7.269 (Pubitemid 40187943)
31. 4 poisoning? Free Radical Biology and Medicine 2005 38 6 698 710 2-s2.0-13844297589 10.1016/j.freeradbiomed.2004.09. 017 (Pubitemid 40249740)
32. Fessel J. P., Porter N. A., Moore K. P., Sheller J. R., Roberts L. J. II, Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proceedings of the National Academy of Sciences of the United States of America 2002 99 26 16713 16718 2-s2.0-0037168540 10.1073/pnas.252649099 (Pubitemid 36034038)
33. Montine K. S., Quinn J. F., Zhang J., Fessel J. P., Roberts L. J. II, Morrow J. D., Montine T. J., Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chemistry and Physics of Lipids 2004 128 1-2 117 124 2-s2.0-0842346368 10.1016/j.chemphyslip.2003.10.010 (Pubitemid 38167381)
34. Corcoran A., Cotter T. G., Redox regulation of protein kinases. FEBS Journal 2013 280 9 1944 1965 10.1111/febs.12224
35. Mas E., Barden A. E., Corcoran T. B., Phillips M., Roberts L. J. II, Mori T. A., Effects of spinal or general anesthesia on F2-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery. Free Radical Biology and Medicine 2011 50 9 1171 1176 2-s2.0-79953246782 10.1016/j.freeradbiomed.2011.01.021
36. Arneson K. O., Roberts L. J. II, Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Methods in Enzymology 2007 433 127 143 2-s2.0-38449114957 10.1016/S0076-6879(07)33007-3
37. Powell H. A., Iyen-Omofoman B., Hubbard R. B., Baldwin D. R., Tata L. J., The association between smoking quantity and lung cancer in men and women. Chest 2013 143 1 123 129
38. Schottenfeld D., Beebe-Dimmer J. L., Buffler P. A., Omenn G. S., Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. Annual Review of Public Health 2013 34 97 117
39. D'Autreaux B., Toledano M. B., ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature Reviews Molecular Cell Biology 2007 8 813 824 (Pubitemid 47462134)
40. Kandel E. S., Mutations in circulating mitochondrial DNA: cassandra of oral cancer? Oncotarget 2012 3 7 664 665
41. Fendt L., Niederstätter H., Huber G., Zelger B., Dünser M., Seifarth C., Röck A., Schäfer G., Klocker H., Parson W., Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection. Breast Cancer Research and Treatment 2011 128 2 327 336 2-s2.0-79959757175 10.1007/s10549-010-1092-8
42. Cui H., Kong Y., Zhang H., Oxidative stress, mitochondrial dysfunction, and aging. Journal of Signal Transduction 2012 2012 13 646354 10.1155/2012/646354
43. Trachootham D., Alexandre J., Huang P., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery 2009 8 7 579 591 2-s2.0-67650071137 10.1038/nrd2803
44. Rodrigues M. S., Reddy M. M., Sattler M., Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implications. Antioxidants and Redox Signaling 2008 10 10 1813 1848 2-s2.0-49749099639 10.1089/ars.2008.2071
45. Peddireddy V., Siva Prasad B., Gundimeda S. D., Penagaluru P. R., Mundluru H. P., Assessment of 8-oxo-7, 8-dihydro-2′-deoxyguanosine and malondialdehyde levels as oxidative stress markers and antioxidant status in non-small cell lung cancer. Biomarkers 2012 17 3 261 268 2-s2.0-84860358440 10.3109/1354750X.2012.664169
46. Balestrieri M. L., Dicitore A., Benevento R., di Maio M., Santoriello A., Canonico S., Giordano A., Stiuso P., Interplay between membrane lipid peroxidation, transglutaminase activity, and Cyclooxygenase 2 expression in the tissue adjoining to breast cancer. Journal of Cellular Physiology 2012 227 4 1577 1582 2-s2.0-84855723034 10.1002/jcp.22874
47. Bhagat S. S., Ghone R. A., Suryakar A. N., Hundekar P. S., Lipid peroxidation and antioxidant vitamin status in colorectal cancer patients. Indian Journal of Physiology and Pharmacology 2011 55 1 72 76 2-s2.0-79953270403
48. Dillioglugil M. O., Mekik H., Muezzinoglu B., Ozkan T. A., Demir C. G., Dillioglugil O., Blood and tissue nitric oxide and malondialdehyde are prognostic indicators of localized prostate cancer. International Urology and Nephrology 2012 44 6 1691 1696
49. Marakala V., Malathi M., Shivashankara A. R., Lipid peroxidation and antioxidant vitamin status in oral cavity and oropharyngeal cancer patients. Asian Pacific Journal of Cancer Prevention 2012 13 11 5763 5765
50. Czeczot H., Scibior-Bentkowska D., Skrzycki M., Podsiad M., Assessment of lipid peroxidation level in serum of patients with gastrointestinal tract tumors. Wiadomości Lekarskie 2010 63 3 180 187 2-s2.0-79952116236
51. Epplein M., Franke A. A., Cooney R. V., Morris J. S., Wilkens L. R., Goodman M. T., Murphy S. P., Henderson B. E., Kolonel L. N., Le Marchand L., Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study. Cancer Epidemiology Biomarkers and Prevention 2009 18 7 1962 1970 2-s2.0-67650439250 10.1158/1055-9965.EPI-09-0003
52. Barocas D. A., Motley S., Cookson M. S., Chang S. S., Penson D. F., Dai Q., Milne G., Roberts L. J. II, Morrow J., Concepcion R. S., Smith J. A. Jr., Fowke J. H., Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. Journal of Urology 2011 185 6 2102 2107 2-s2.0-79955840207 10.1016/j.juro.2011.02.020
53. Asombang A. W., Kayamba V., Mwanza-Lisulo M., Gastric cancer in Zambian adults: a prospective case-control study that assessed dietary intake and antioxidant status by using urinary isoprostane excretion. The American Journal of Clinical Nutrition 2013 97 5 1029 1035 10.3945/ajcn.112.051284
54. Germain E., Chajes V., Cognault S., Lhuillery C., Bougnoux P., Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. International Journal of Cancer 1998 75 4 578 583 (Pubitemid 28094104)
55. Wu X. X., Ogawa O., Kakehi Y., Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. International Journal of Oncology 2004 24 6 1489 1497 2-s2.0-16544375170
56. Baumgartner M., Sturlan S., Roth E., Wessner B., Bachleitner-Hofmann T., Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. International Journal of Cancer 2004 112 4 707 712 2-s2.0-7044234956 10.1002/ijc.20462 (Pubitemid 39425954)
57. Fahrmann J. F., Hardman W. E., Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine. Lipids in Health and Disease 2013 12, article 36
58. Benais-Pont G., Dupertuis Y. M., Kossovsky M. P., Nouet P., Allal A. S., Buchegger F., Pichard C., ω -3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. Nutrition 2006 22 9 931 939 2-s2.0-33747200855 10.1016/j.nut.2006.05.012 (Pubitemid 44234013)
59. Rudra P. K., Krokan H. E., Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive- and resistant human tumor cells. Anticancer Research 1999 19 1 461 469 2-s2.0-0032945381 (Pubitemid 29168278)
60. Yang E. S., Woo S. M., Choi K. S., Kwon T. K., Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2. Experimental Cell Research 2011 317 18 2592 2601 2-s2.0-80053560823 10.1016/j.yexcr.2011.08.005
61. Pettazzoni P., Pizzimenti S., Toaldo C., Sotomayor P., Tagliavacca L., Liu S., Wang D., Minelli R., Ellis L., Atadja P., Ciamporcero E., Dianzani M. U., Barrera G., Pili R., Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. Free Radical Biology and Medicine 2011 50 2 313 322 2-s2.0-78651244903 10.1016/j.freeradbiomed.2010.11.011
62. Nagai M., Vo N. H., Shin Ogawa L., The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radical Biology and Medicine 2012 52 10 2142 2150
63. Rasul A., Bao R., Malhi M., Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction. Molecules 2013 18 2 1418 1433
64. Zhang S., He Y., Tong Q., Chen Q., Wu X., Huang W., Deltonin induces apoptosis in MDAMB231 human breast cancer cells via reactive oxygen speciesmediated mitochondrial dysfunction and ERK/AKT signaling pathways. Molecular Medicine Reports 2013 7 3 1038 1044
65. Gonzalez M. J., Schemmel R. A., Gray J. I., Dugan L. Jr., Sheffield L. G., Welsch C. W., Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis 1991 12 7 1231 1235 2-s2.0-0025815902
66. Shao Y., Pardini L., Pardini R. S., Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 1995 30 11 1035 1045 2-s2.0-0028821851 10.1007/BF02536289
67. Tsuzuki T., Tokuyama Y., Igarashi M., Miyazawa T., Tumor growth suppression by α -eleostearic acid, a linolenic acid isomer with a cunjugated triene system, via lipid peroxidation. Carcinogenesis 2004 25 8 1417 1425 2-s2.0-4344715276 10.1093/carcin/bgh109 (Pubitemid 39162707)
68. Kumar S., Kokate R. A., Sahu M., Chaudhary P., Sharma R., Awasthi S., Awasthi Y. C., Inhibition of mercapturic acid pathway-mediated disposal of 4-hydroxynonenal causes complete and sustained remission of human cancer xenografts in nude mice. Indian Journal of Experimental Biology 2011 49 11 817 825 2-s2.0-80355141493
69. Salzman R., Pácal L., Tomandl J., Kaňková K., Tóthová E., Gál B., Kostřica R., Salzman P., Elevated malondialdehyde correlates with the extent of primary tumor and predicts poor prognosis of oropharyngeal cancer. Anticancer Research 2009 29 10 4227 4231 2-s2.0-71949129504
70. Chole R. H., Patil R. N., Basak A., Palandurkar K., Bhowate R., Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. Journal of Cancer Research and Therapeutics 2010 6 4 487 491 2-s2.0-79952374815 10.4103/0973-1482.77106
71. Ahmad R., Tripathi A. K., Tripathi P., Singh R., Singh S., Singh R. K., Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia. Singapore Medical Journal 2010 51 2 110 115 2-s2.0-77951290573
72. Karihtala P., Kauppila S., Puistola U., Jukkola-Vuorinen A., Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis. Histopathology 2011 58 6 854 862 2-s2.0-79956122656 10.1111/j.1365-2559.2011.03835.x
73. Mosina L. M., Tarasova T. V., Soldatova E. M., Chibisov S. M., Avde kina O. I., Kotliarov A. A., Parameters of oxidative stress in patients with gastric cancer. Klinicheskaia Meditsina 2011 89 3 50 53 2-s2.0-80052895367
74. Misthos P., Katsaragakis S., Milingos N., Kakaris S., Sepsas E., Athanassiadi K., Theodorou D., Skottis I., Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation. European Journal of Cardio-thoracic Surgery 2005 27 3 379 383 2-s2.0-14644414146 10.1016/j.ejcts.2004.12.023 (Pubitemid 40312341)
75. Surinenaite B., Prasmickiene G., Milašiene V., Stratilatovas E., Didžiapetriene J., The influence of surgical treatment and red blood cell transfusion on changes in antioxidative and immune system parameters in colorectal cancer patients. Medicina 2009 45 10 785 791 2-s2.0-77449154050
76. Liu D., Xu Y., P53: oxidative stress, and aging. Antioxidants and Redox Signaling 2011 15 6 1669 1678 2-s2.0-79961180595 10.1089/ars.2010.3644
77. Wei J., Zaika E., Zaika A., p53 family: role of protein isoforms in human cancer. Journal of Nucleic Acids 2012 2012 19 687359 10.1155/2012/687359 687359
78. Laurora S., Tamagno E., Briatore F., Bardini P., Pizzimenti S., Toaldo C., Reffo P., Costelli P., Dianzani M. U., Danni O., Barrera G., 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radical Biology and Medicine 2005 38 2 215 225 2-s2.0-20844451539 10.1016/j.freeradbiomed.2004.10.014 (Pubitemid 39656132)
79. Lewis K. A., Wuttke D. S., Telomerase and telomere-associated proteins: structural insights into mechanism and evolution. Structure 2012 20 1 28 39 2-s2.0-84855763327 10.1016/j.str.2011.10.017
80. Pizzimenti S., Briatore F., Laurora S., Toaldo C., Maggio M., De Grandi M., Meaglia L., Menegatti E., Giglioni B., Dianzani M. U., Barrera G., 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radical Biology and Medicine 2006 40 9 1578 1591 2-s2.0-33646040063 10.1016/j.freeradbiomed.2005.12.024
81. Pizzimenti S., Menegatti E., Berardi D., Toaldo C., Pettazzoni P., Minelli R., Giglioni B., Cerbone A., Dianzani M. U., Ferretti C., Barrera G., 4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity. Journal of Nutritional Biochemistry 2010 21 9 818 826 2-s2.0-77955843950 10.1016/j.jnutbio.2009.06.005
82. Berg T., Small-molecule modulators of c-Myc/Max and Max/Max interactions. Current Topics in Microbiology and Immunology 2011 348 139 149 2-s2.0-79957510937 10.1007/82-2010-90
83. Whitfield J. R., Soucek L., Tumor microenvironment: becoming sick of Myc. Cellular and Molecular Life Sciences 2012 69 6 931 934 2-s2.0-84857648310 10.1007/s00018-011-0860-x
84. Dang C. V., MYC on the path to cancer. Cell 2012 149 1 22 35 2-s2.0-84859171807 10.1016/j.cell.2012.03.003
85. Vafa O., Wade M., Kern S., Beeche M., Pandita T. K., Hampton G. M., Wahl G. M., c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Molecular Cell 2002 9 5 1031 1044 2-s2.0-0036285034 10.1016/S1097-2765(02)00520- 8 (Pubitemid 34626672)